NCT00202397View on ClinicalTrials.gov

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Hereditary AtaxiaMultiple SclerosisCerebellar Ataxia
Interventions
DRUG

Riluzole

capsule-shaped 50 mg tablets bid for 8 weeks

OTHER

placebo

capsule-shaped tablet bid for 8 weeks

Trial Locations (1)

00100

"S.Andrea Hospital - University of Rome La Sapienza", Rome

All Listed Sponsors
lead

S. Andrea Hospital

OTHER

NCT00202397 - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia | Biotech Hunter | Biotech Hunter